Announcement on the Revision and Explanation of the Major Asset Purchase Report (Draft)

Dongxing Medical Co., Ltd.·June 12, 2026·2 pages

✨ AI Summary

Jiangsu Dongxing Smart Medical Technology Co., Ltd. announces revisions to its major asset purchase report. The changes address supplementary agreements on performance commitments, update business qualifications, and disclose insider trading self-inspection results. These revisions aim to provide a more comprehensive and accurate disclosure regarding the acquisition.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 301290

Securities Abbreviation: Dongxing Medical

Announcement No.: 2026-032

Jiangsu Dongxing Smart Medical Technology Co., Ltd.

Announcement on the Revision and Explanation of the Major Asset Purchase Report (Draft)

The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.

I. Basic情况 of the Transaction

Jiangsu Dongxing Smart Medical Technology Co., Ltd. (hereinafter referred to as the "Listed Company" or the "Company") intends to acquire 90% of the equity of Wuhan Yijia Bao Medical Materials Co., Ltd. (hereinafter referred to as the "Target Company" or "Yijia Bao") held by Bao Shijun and Hubei Tianhui Technology Development Co., Ltd. (hereinafter referred to as the "Transaction Counterparties") by paying cash (hereinafter referred to as the "Transaction").

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.